October 2019

Successful informative session on U.S. Non-dilutive funding at IDIBELL

Leave a Comment / Uncategorised / By

The “U.S. Federal sources for health Projects” informative session was successfully held at IDIBELL last October 21st. Jointly co-organized with AGAUR, the Agency for Management of University and Research Grants, the session featured two seminars on U.S. funding sources for Health Projects, that were delivered by Dr. Ana Turchetti-Maia, Director of Business Development at Freemind […]

Successful informative session on U.S. Non-dilutive funding at IDIBELL Read More »

The consul general of France in Barcelona visits IDIBELL

Leave a Comment / Hereditary cancer , Radiobiology & Cancer / By

The consul general of France in Barcelona, Cyril Piquemal, visited IDIBELL on October 23rd in order to get to know the institute and promote collaborations and synergies with French institutions. The visit took place as part of the efforts made by the French consulate to strengthen the interaction between research centers in Catalonia and France.

The consul general of France in Barcelona visits IDIBELL Read More »

Humanizing worms makes them sensitive to a cancer drug and identifies weak points of tumor cells

Leave a Comment / Modeling human diseases in C. elegans , Traslacional Medicine / By

At first glance, a one-millimeter worm that needs to be observed with a magnifying glass does not resemble a human being at all. However, the nematode Caenorhabditis elegans, an animal model widely used in biomedical research by hundreds of laboratories around the world, has approximately the same number of genes that humans have, about 20,000.

Humanizing worms makes them sensitive to a cancer drug and identifies weak points of tumor cells Read More »

IDIBELL and Sant Joan de Déu join efforts to create the first animal model of Sturge-Weber Syndrome

Leave a Comment / Cancer, Tumour Angiogenesis, Vascular biology and signalling  / By

The project is led by Dr. Eulàlia Baselga, Area of Dermatology of the Hospital Sant Joan de Déu Barcelona, and Dr. Mariona Graupera, Bellvitge Biomedical Research Institute (IDIBELL). Its main objective is to identify a treatment aimed at reversing or improving the vascular alterations produced by the R183Q mutation in the GNAQ gene that leads to Sturge-Weber Syndrome.

IDIBELL and Sant Joan de Déu join efforts to create the first animal model of Sturge-Weber Syndrome Read More »

Innovation for value, the first international innovation conference at IDIBELL

Innovation, Sin categorizar / By

On November 8, IDIBELL and ITEMAS co-organize Innovation for Value (#I4V), a conference focusing on the opportunities offered by innovation and new technologies in the healthcare field. In this event, which will take place at the Bellvitge University Hospital, speakers will also analyze the new business opportunities that arise thanks to scientific innovation and the

Innovation for value, the first international innovation conference at IDIBELL Read More »

A medicine for prostatic hyperplasia could help slow the progression of Parkinson’s disease

Leave a Comment / Neuroscience Program, Stem Cell Potency , Stem cells and Neurodegenerative diseases / By

Parkinson’s disease (PD) is an old age disorder that causes a series of motor deficiencies that are characteristic. Normally, the four main symptoms are hand tremor, limb stiffness, slowness and impaired balance. With the progression of the disease, patients may also experience dementia and other neurological disorders. Since the main symptoms are due to degeneration

A medicine for prostatic hyperplasia could help slow the progression of Parkinson’s disease Read More »

Scroll to Top